XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
29-11-2017

Bahan aktif:

levocetirizine dihydrochloride, Quantity: 5 mg/mL

Boleh didapati daripada:

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

INN (Nama Antarabangsa):

levocetirizine dihydrochloride

Borang farmaseutikal:

Oral Liquid

Komposisi:

Excipient Ingredients: purified water; propylene glycol; glycerol; acetic acid; saccharin sodium; methyl hydroxybenzoate; propyl hydroxybenzoate; sodium acetate

Laluan pentadbiran:

Oral

Unit dalam pakej:

1 x 15mL bottle, 1 x 20mL bottle, 1 x 10 mL bottle

Jenis preskripsi:

(S2) Pharmacy Medicine

Tanda-tanda terapeutik:

Xyzal oral drops are indicated for the symptomatic treatment of allergic rhinitis (including persistent rhinitis) and chronic idiopathic urticaria in adults and children aged 2 years and over.

Ringkasan produk:

Visual Identification: Clear, colourless solution; Container Type: Bottle; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Status kebenaran:

Registered

Tarikh kebenaran:

2010-01-19